Apimeds Pharmaceuticals US

APUSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.792 M

$1.85 +10.78%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$6.00M

Loss-making

Shares outstanding

15,091,177

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#487GenprexGNPX$2.90M
#488PRF TechnologiesPRFX$2.83M
#489Apimeds Pharmaceuticals USAPUS$2.79M
#490CDT EquityCDT$2.74M
#491SciSparcSPRC$2.66M

What if Apimeds Pharmaceuticals US were worth as much as…

Open the what-if tool →

Gold $30.2T

$20,034,201

Per share 10,829,298× higher

Bitcoin $1.74T

$1,154,088

Per share 623,831× higher

Nvidia $5.52T

$3,654,961

Per share 1,975,655× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Apimeds Pharmaceuticals US are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.